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A b s t r a c t
Introductuion: Symptomatic severe vertebral artery (VA) stenosis may be treated safely with stent supported angioplasty via 
femoral access. There is limited clinical data on transradial approach for VA angioplasty in case of peripheral artery disease.
Aim: To evaluate the safety and efficacy of transradial angioplasty of symptomatic VA stenosis.
Material and methods: Fifteen patients (age 66 ±7.4 years, 73% men, with VA > 80% stenosis, 11 right-side, all symptomatic 
from posterior circulation (history of stroke, TIA, or chronic ischaemia symptoms)) with peripheral artery disease (PAD) or unsuc-
cessful attempt via femoral approach were scheduled for VA angioplasty by radial access. Clinical and duplex ultrasound (DUS) 
follow-up were performed before discharge and 1, 12, and 24 months after VA angioplasty.
Results: The technical success rate was 100%. In all cases VA angioplasty was performed with the use of single balloon-mount-
ed stent (9 bare metal stents, 6 drug-eluting stents). The mean NASCET VA stenosis was reduced from 85.3% to 5.3% (p < 0.001). 
No periprocedural death, stroke, myocardial infarction, or transient ischaemic attack occurred. During 24-months follow-up, in 12 of 
15 patients chronic ischaemia symptoms release was observed, and no new acute ischaemic neurological symptoms were diag-
nosed in all patients. One patient died 20 months after intervention from unknown causes. There was one symptomatic borderline 
VA in-stent stenosis 12 months after angioplasty.
Conclusions: Transradial VA stenting may be a very effective and safe procedure, and it may constitute an alternative to the 
femoral approach in patients with symptomatic VA stenosis.
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Introduction
Stroke remains a major cause of mortality and dis-
ability in adults. Approximately one quarter of ischaemic 
strokes are located in the posterior circulation [1, 2]. Ath-
erosclerotic stenosis of the vertebral artery (VA) is a po-
tential cause of vertebrobasilar ischaemia and may ac-
count for about 20% of posterior circulation strokes [3]. 
Ostium is the most frequent location of VA stenosis. 
Vertebral artery stenting via transfemoral approach 
has been shown to be safe and effective in the peripro-
cedural period as well as in long-term follow-up [4]. Tran-
sradial access recently received an IA recommendation 
as it was demonstrated to be the safest way to perform 
coronary territory interventions [5]. Moreover, it has been 
successfully applied also for carotid artery stenting [6, 7]. 
Thus, in patients with severe symptomatic VA stenosis 
with coexisting peripheral artery disease or unfavourable 
aortic arch/subclavian artery anatomy, transradial access 
might be a  viable alternative to the transfemoral ap-
proach. Transradial coronary intervention experience may 
increase the chance for success in vertebral territory [8].
Aim
We report transradial VA angioplasty outcome in 
15 patients with peripheral artery disease or unsuccess-
ful attempt from femoral access. 
Material and methods
Between Jan 2010 and Jul 2014, 15 patients with se-
vere, symptomatic VA stenosis were included in study. Ta-
ble I shows patient characteristics. All VA stenosis as well 
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as aortic arch anatomy were demonstrated in computed 
tomographic angiography (Figure 1 A). Transfemoral ac-
cess was not feasible due to peripheral artery disease 
(PAD) in 8 (53%) patients and due to severe subclavian 
artery tortuosity in 7 (47%) patients. 
All patients underwent examination by the site neu-
rologist. Chronic posterior circulation ischaemia (dizzi-
ness/unilateral limb weakness/dysarthria/blurred vision) 
were diagnosed in 15 (100%) patients, recurrent drop at-
tacks in 3 (20%), and history of vertebrobasilar stroke/ 
transient ischaemic attack (TIA) in 2 (13%) patients. 
All patients had been treated protractedly with aspirin 
(75 mg per day), and prior to the procedure they received 
a 300 mg loading dose of clopidogrel. After the VA angio-
plasty, the aspirin was maintained indefinitely, and 75 mg 
per day of clopidogrel was continued for 1 month for bare 
metal stent and 12 months for drug-eluting stent. On the 
procedure day, the ipsilateral radial artery was punctured 
and a 6 Fr short arterial sheath was introduced. Heparin 
was given to achieve an activated coagulation time of 
250 to 300 s. Over 0.035 inch (0.889 mm) diagnostic wire 
Judkins Right 4.0/6 Fr guiding catheter was advanced to-
ward VA ostium (Figures 1 B, 2 A). In all patients 0.014 inch 
(0.356 mm) coronary guidewire was positioned at the dis-
tal segment of the vertebral artery. In 1 patient with soft 
plaque proximal vertebral stenosis FilterWire EZ (Boston 
Scientific) distal embolic protection device was used to 
minimise the risk of distal embolisation (Figure 2 B). 
Direct stenting was performed when possible. Before 
and after stent deployment, the degree of stenosis was 
evaluated by quantitative angiography (Figures 1 C–D, 
2 C–D). Clinical and duplex ultrasound (DUS) control fol-
low-up were performed before discharge and 1, 12, and 
24 months after VA angioplasty. Significant in-stent ste-
nosis criteria were peak systolic velocity > 120 cm/s and/
or end-diastolic velocity > 40 cm/s [9].
Results
Technical success defined as stent implantation 
with residual stenosis < 20%, no significant dissection, 
and TIMI 3 flow was achieved in 15 (100%) patients. In 
one patient asymptomatic stent edge dissection was 
observed and this did not require any additional inter-
vention. In all cases VA angioplasty was performed with 
the use of a single balloon-mounted stent (9 bare metal 
stents, 6 drug-eluting stents). Direct stent implantation 
with 12–20 atm was performed in 9 (60%) cases. At os-
tial location, stents were post-dilated proximally with 
12–22 atm. The mean NASCET VA stenosis was reduced 
from 85.3% to 5.3% (p < 0.001). Procedural data are sum-
marised in Table II. 
No periprocedural death, stroke, myocardial infarc-
tion, or transient ischaemic attack occurred. In 4 (26.6%) 
patients with symptomatic coronary artery disease, cor-
onary angiography was performed. Three (20%) of these 
patients underwent successful percutaneous coronary 
angioplasty 2–4 weeks after VA stenting.
During follow-up (range: 3–57 months, mean: 28.1 
months) in 12 of 15 patients chronic ischaemia symp-
toms release were observed; no new acute ischaemic 
neurological symptoms were diagnosed in all patients. 
One patient died 20 months after intervention from un-
known causes. Follow-up DUS velocities remained stable 
in all patients (mean peak systolic velocity of 1.26 m/s 
(0.5–2.3 m/s); end-diastolic velocity of 0.33 m/s (0.13– 
0.6 m/s). Two cases of DUS-revealed in-stent stenosis 
were not confirmed by computed tomography (CT) an-
giography. There was one symptomatic VA in-stent ste-
nosis 12 months after angioplasty, revealed by DUS. As 
CT confirmed only borderline (50%) in-stent stenosis, the 
patient was not qualified for intervention at that time. 
Discussion
The transfemoral approach is commonly used for 
vertebral artery access [10]. However, aorto-iliac disease 
or unfavourable aortic arch/subclavian artery anatomy 
can make the procedure difficult or even impossible. 
Operators experienced in transradial access in coronary 
interventions may use it also for aortic arch arteries an-
gioplasty, including VA stenting. In fact, those two proce-
dural techniques do not differ much and require a similar 
set of devices and skills. Transfemoral access VA stenting 
usually did not involve the use of a neuroprotection de-
vice [4]. However, in selected cases it might be useful for 
preventing intracranial embolisation during procedures 
[11, 12]. In our series of cases, there was one high-risk 
Table I. Baseline clinical characteristics of pa-
tients (n = 15) 
Parameter Results
Age [years] 66.4 ±7.4
Gender, men  11 (73.3%)
Vertigo  15 (100%)
Recurrent syncope  3 (20%)
Stroke/TIA  2 (13.3%) 
Hypertension  15 (100%)
Diabetes mellitus  5 (33.3%)
Dyslipidaemia  14 (93.3%)
Coronary artery disease  10 (66.6%)
Previous percutaneous intervention coronary  8 (53.3%)
Previous myocardial infarction  5 (33.3%)
History of coronary artery bypass grafting  2 (13.3%)
Peripheral artery disease  8 (53.3%)
Contralateral vertebral artery occlusion 4 (26.6%)
Concurrent carotid disease  4 (26.6%)
Concurrent subclavian disease  2 (13.3%)
Concurrent brachiocephalicus truncus disease  2 (13.3%) 
Prior CVA/TIA* 7 (46.6%)
*Cerebrovascular accident/transient ischaemic attack.
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patient after ischaemic stroke with soft-plaque VA ste-
nosis in whom we decided to apply distal embolic protec-
tion FilterWire EZ (Boston Scientific) with good result. No 
macroscopic embolic material was found in the system 
basket. 
The well-known benefits of radial access are fewer 
vascular access complications and less major bleeding 
events, when compared with the femoral approach espe-
cially in the older population and/or in patients receiving 
dual antiplatelet therapy – as in our series. Early mobili-
sation is another key advantage of the transradial tech-
nique, especially in older patients [13]. Duplex ultrasound 
plays an important role in the assessment of VA stenosis 
or in-stent stenosis; however, the demanding examina-
tion technique and interpretation may pose a  serious 
problem for the operator. Therefore, VA DUS should be 
Figure 1. A – Left subclavian artery occlusion and right vertebral ostium stenosis (large arrow) diagnosed in CT 
angiography. B – Angiography confirming vertebral stenosis. C – Skylor 4.5 mm × 13 mm post-dilatation. D – Fi-
nal angiography showing optimal effect of VAS
RVA – right vertebral artery, LVA – left vertebral artery, CCT – costocervical trunk, TCT – thyrocervical trunk.
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performed by experienced physicians. For example, tor-
tuosity in the proximal part of VA or compensation of 
flow in case of contralateral VA occlusion may result in 
a significant increase in flow velocities. When in doubt, 
Figure 2. A – Selective angiography confirming right vertebral artery stenosis. B – FilterWire EZ distal embolic 
protection device (arrow). C – Balloon-expandable Nefro 5 mm × 14 mm direct stenting. D – Final effect of 
transradial VAS
A
C
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D
CT angiography may be the best tool for precise artery 
stenosis degree evaluation. Computed tomography an-
giography also demonstrates high accuracy for diagnosis 
of VA in-stent stenosis [14].
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Table II. Procedural data
Parameter Results 
Left vertebral 4 (26.6%) 
Right vertebral 11 (73.3%)
Balloon-expandable baremetal stent 9 (60%)
Balloon-expandable drug-eluting stent 6 (40%)
Stent diameter [mm] 2.75–5.5
Stent length [mm] 6–19
Direct stenting 9 (60%)
Angiographic stenosis evaluation [%]:
Pre-intervention 86.4 ±8.7
Post-intervention 5.3 ±6.4
Conclusions
Our data shows that transradial VA stenting may be 
a very effective and safe procedure, and it may consti-
tute an alternative to the femoral approach in patients 
with symptomatic VA stenosis. This refers especially to 
patients with PAD or with unfavourable aortic arch/sub-
clavian artery anatomy.
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